HYEP IVAN (Chief Financial Officer) sold 6.0% of their position (9.20K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $187.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/26/2026ACC: 0001628280-26-038248
Officer· Chief Financial Officer
Since Mar 2026
-9.20K
Net shares
Net seller
$187.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.20K acquired · 18.40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.20K
Price / share
$3.79
Trade value
$34.87K
% of position
6.3%
5/21/2026
145.35K→154.56K
Common Stock
Direct
Shares
−9.20K
Price / share
$20.42
Trade value
$187.88K
% of position
6.0%
5/21/2026
154.56K→145.35K
Total
Net shares
+0.00
Net value
-$153.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | M · Option Exercise | +9.20K | $3.79 | $34.87K | 6.3% | 145.35K | 154.56K |
| Common Stock Direct | 5/21/2026 | S · Sale | −9.20K | $20.42 | $187.88K | 6.0% | 154.56K | 145.35K |
| Total | +0.00 | -$153.02K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
9.20K shares
Shares
−9.20K
Strike price
3.7898
Held after
70.58K
Exercisable
—
5/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock9.20K shares | 5/21/2026 | M · Option Exercise | −9.20K | 3.7898 | — | 70.58K |